Study EvAluating Genotypes While Using Lucentis 2

NCT01464723 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: Ranibizumab

Sponsor

University of California, San Diego

Collaborators

[object Object]